US FDA grants breakthrough therapy designation to Innate Pharma’s lacutamab for relapsed or refractory Sézary syndrome: Marseille, France Tuesday, February 18, 2025, 12:00 Hrs ...

Innate Pharma has secured US Food and Drug Administration (FDA) breakthrough therapy designation for lacutamab to treat ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to ...

Acitretin (Soriatane ®) and bexarotene are the two orally available retinoids used most commonly for treating MF. These drugs are derivatives of vitamin A and are in the same class of agents as ...

Symptom control is often the goal for patients who have mycosis fungoides, the most common type of cutaneous T-cell lymphoma. Mycosis fungoides tends to advance slowly, so symptom control can help you ...

In some people with psoriasis, nail symptoms are the first to appear. A nail fungal infection, also known as tinea unguium or onychomycosis, is an infection that can affect the nail plate ...

Without proper treatment, tooth infections can spread to other areas of the body, leading to serious and potentially life threatening complications. A tooth infection, or a tooth abscess, is a ...

Rotating can help reduce pain when ongoing injections are needed. It may also reduce the risk of tissue scarring. Subcutaneous injections are those delivered in the fatty tissue that lies between the ...

The subcutaneous formulation of Opdivo Qvantig reduces administration time to three to five minutes, compared to 30 minutes for the IV version. This formulation offers increased convenience, ...

Jock itch, or tinea cruris, is a fungal infection that can cause itchiness in the groin or inner thighs. Home remedies and prescription medications can help ease symptoms and prevent the infection ...

The trial investigated the safety, tolerability, pharmacokinetics, and proof-of-concept after once-weekly subcutaneous administrations of amycretin in 125 people with overweight or obesity.